The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 7810 -7817
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Getachew, Y.
Right arrow Articles by Thiele, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Getachew, Y.
Right arrow Articles by Thiele, D. L.

Granzyme C Supports Efficient CTL-Mediated Killing Late in Primary Alloimmune Responses1

Yonas Getachew*, Heather Stout-Delgado*,{dagger}, Bonnie C. Miller*,{dagger} and Dwain L. Thiele2,*,{dagger}

* Division of Digestive and Liver Diseases, Department of Internal Medicine, and {dagger} Immunology Graduate Program, University of Texas Southwestern Medical Center, Dallas, TX 75390

It is well established that granzymes A and B play a role in CTL killing of target cells by the perforin-dependent granule exocytosis pathway. The functions of multiple additional granzymes expressed in CTL are less well defined. In the present studies, CTL generated from mice deficient in dipeptidyl peptidase 1 (DPP1) were used to investigate the contribution of granzyme C to CTL killing of allogeneic target cells. DPP1 is required for activation of granzymes A and B by proteolytic removal of their N-terminal dipeptide prodomains while a significant portion of granzyme C is processed normally in the absence of DPP1. Cytotoxicity of DPP1–/– CTL generated in early (5-day) MLC in vitro and in peritoneal exudate cells 5 days after initial allogeneic sensitization in vivo was significantly impaired compared with wild-type CTL. Following 3 days of restimulation with fresh allogeneic stimulators however, cytotoxicity of these DPP1–/– effector cells was comparable to that of wild-type CTL. Killing mediated by DPP1–/– CTL following restimulation was rapid, perforin dependent, Fas independent and associated with early mitochondrial injury, phosphatidyl serine externalization, and DNA degradation, implicating a granzyme-dependent apoptotic pathway. The increased cytotoxicity of DPP1–/– CTL following restimulation coincided with increased expression of granzyme C. Moreover, small interfering RNA inhibition of granzyme C expression during restimulation significantly decreased cytotoxicity of DPP1–/– but not wild-type CTL. These results indicate that during late primary alloimmune responses, granzyme C can support CTL-mediated killing by the granule exocytosis pathway in the absence of functional granzymes A or B.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants R01 DK53933 and AI24639 (to D.L.T.) and 3T32 DK007745 (to Y.G.).

2 Address correspondence and reprint requests to Dr. Dwain L. Thiele, Department of Internal Medicine, 5323 Harry Hines Boulevard, Dallas, TX 75390-9151. E-mail address: dwain.thiele{at}utsouthwestern.edu

3 Abbreviations used in this paper: FasL, Fas ligand; Gzm, granzyme; 7-AAD, 7-aminoactinomycin D; siRNA, small interfering RNA; qRT-PCR, quantitative RT-PCR; WT, wild type.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. F. Cai, T. A. Fehniger, X. Cao, J. C. Mayer, J. D. Brune, A. R. French, and T. J. Ley
Differential Expression of Granzyme B and C in Murine Cytotoxic Lymphocytes
J. Immunol., May 15, 2009; 182(10): 6287 - 6297.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.